AstraZeneca Pharma India Limited – NSE:ASTRAZEN.NS
AstraZeneca Pharma India Limited stock price today
AstraZeneca Pharma India Limited stock price monthly change
AstraZeneca Pharma India Limited stock price quarterly change
AstraZeneca Pharma India Limited stock price yearly change
AstraZeneca Pharma India Limited key metrics
Market Cap | 161.43B |
Enterprise value | 154.17B |
P/E | 194.07 |
EV/Sales | 10.38 |
EV/EBITDA | 116.45 |
Price/Sales | 10.70 |
Price/Book | 23.40 |
PEG ratio | -0.87 |
EPS | 64.6 |
Revenue | 12.95B |
EBITDA | 2.10B |
Income | 1.61B |
Revenue Q/Q | 34.59% |
Revenue Y/Y | 29.16% |
Profit margin | 5.52% |
Oper. margin | 6.79% |
Gross margin | 36.35% |
EBIT margin | 6.79% |
EBITDA margin | 16.25% |
create your own Smart Feed
Personalize your watchlist with companies you want to keep track of and get notified in the smart feed every time fresh news arrives.
Sign up for freeAstraZeneca Pharma India Limited stock price history
AstraZeneca Pharma India Limited stock forecast
AstraZeneca Pharma India Limited financial statements
| Jun 2023 | 2.95B | 538.60M | 18.23% |
|---|---|---|---|
| Sep 2023 | 3.11B | 523.69M | 16.84% |
| Dec 2023 | 3.05B | 158.00M | 5.17% |
| Mar 2024 | 3.83B | 394.74M | 10.3% |
| Payout ratio | 0% |
|---|
| 2016 | |
|---|---|
| 2017 | |
| 2019 | |
| 2020 | 0.05% |
| 2022 | 0.08% |
| Jun 2023 | 0 | 0 | |
|---|---|---|---|
| Sep 2023 | 11015513000 | 4.46B | 40.54% |
| Dec 2023 | 0 | 0 | |
| Mar 2024 | 10780283000 | 3.66B | 33.96% |
| Mar 2023 | 23.7M | 0 | 0 |
|---|---|---|---|
| Jun 2023 | 75.95M | 0 | 0 |
| Sep 2023 | 73.47M | 0 | 0 |
| Dec 2023 | 74.09M | 0 | 0 |
AstraZeneca Pharma India Limited alternative data
| Aug 2023 | 1,183 |
|---|---|
| Sep 2023 | 947 |
| Oct 2023 | 947 |
| Nov 2023 | 947 |
| Dec 2023 | 947 |
| Jan 2024 | 947 |
| Feb 2024 | 947 |
| Mar 2024 | 947 |
| Apr 2024 | 947 |
| May 2024 | 947 |
| Jun 2024 | 900 |
| Jul 2024 | 900 |
AstraZeneca Pharma India Limited other data
| Insider | Compensation |
|---|---|
Mr. Gagandeep Singh Bedi (1971) MD, Country Pres & Executive Director | $49,610,000 |
Mr. Rajesh Marwaha (1963) Chief Financial Officer & Executive Director | $27,450,000 |
-
What's the price of AstraZeneca Pharma India Limited stock today?
One share of AstraZeneca Pharma India Limited stock can currently be purchased for approximately $3,081.25.
-
When is AstraZeneca Pharma India Limited's next earnings date?
Unfortunately, AstraZeneca Pharma India Limited's (ASTRAZEN.NS) next earnings date is currently unknown.
-
Does AstraZeneca Pharma India Limited pay dividends?
Yes, AstraZeneca Pharma India Limited pays dividends and its trailing 12-month yield is 0.38% with 0% payout ratio. The last AstraZeneca Pharma India Limited stock dividend of $0 was paid on 12 Sep 2025.
-
How much money does AstraZeneca Pharma India Limited make?
AstraZeneca Pharma India Limited has a market capitalization of 161.43B and it's past years’ income statements indicate that its last revenue has increased compared to the previous period by 60.82% to 12.96B US dollars.
-
What is AstraZeneca Pharma India Limited's stock symbol?
AstraZeneca Pharma India Limited is traded on the NSE under the ticker symbol "ASTRAZEN.NS".
-
What is AstraZeneca Pharma India Limited's primary industry?
Company operates in the Healthcare sector and Drug Manufacturers - Specialty & Generic industry.
-
How do i buy shares of AstraZeneca Pharma India Limited?
Shares of AstraZeneca Pharma India Limited can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
-
Who are AstraZeneca Pharma India Limited's key executives?
AstraZeneca Pharma India Limited's management team includes the following people:
- Mr. Gagandeep Singh Bedi MD, Country Pres & Executive Director(age: 54, pay: $49,610,000)
- Mr. Rajesh Marwaha Chief Financial Officer & Executive Director(age: 62, pay: $27,450,000)
-
How many employees does AstraZeneca Pharma India Limited have?
As Jul 2024, AstraZeneca Pharma India Limited employs 900 workers, which is 5% less then previous quarter.
-
When AstraZeneca Pharma India Limited went public?
AstraZeneca Pharma India Limited is publicly traded company for more then 23 years since IPO on 1 Jul 2002.
-
What is AstraZeneca Pharma India Limited's official website?
The official website for AstraZeneca Pharma India Limited is astrazeneca.in.
-
How can i contact AstraZeneca Pharma India Limited?
AstraZeneca Pharma India Limited can be reached via phone at +91 80677 48000.
AstraZeneca Pharma India Limited company profile:
AstraZeneca Pharma India Limited
astrazeneca.inNSE
940
Drug Manufacturers - Specialty & Generic
Healthcare
AstraZeneca Pharma India Limited, a biopharmaceutical company, manufactures, distributes, and markets pharmaceutical products in India and internationally. It manufactures and sells cardiovascular disease and diabetes medicines under the Brilinta, Betaloc, Crestor, Forxiga, Imdur, Kombiglyze XR, Onglyza, Seloken XL, Xigduo XR, and QTERN brands; Respiratory medicines under the Symbicort and FASENRA brand names; and oncology medicines under the LYNPARZA, Tagrisso, Iressa, Calquence, Casodex, Faslodex, Zoladex, and Arimidex brands. The company also offers products in the areas of renal, metabolic, and immunology diseases. It also provides clinical trial services. The company was incorporated in 1979 and is based in Bengaluru, India. AstraZeneca Pharma India Limited is a subsidiary of AstraZeneca Pharmaceuticals AB.
Bengaluru, 560045
:
ISIN: INE203A01020
CUSIP: Y0431U139
